Medical device maker Insulet convinced a jury that Korean rival EOFlow owes it $452 million in damages for stealing trade ...

Insulet Corp., manufacturer of the tubeless Omnipod Insulin Management System, has been awarded $452 million in damages after it successfully defended its intellectual property against ...

Insulin pump maker Insulet won $452 million in its trade secret case against Korean rival EOFlow, the company announced on ...

The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create ...

Dec 5 (Reuters) - Medical device maker Insulet (PODD.O), opens new tab convinced a jury that Korean rival EOFlow (294090.KQ), opens new tab owes it $452 million in damages for stealing trade ...

Insulet, an Acton medical device manufacturer, has been awarded $452 million in total damages by a federal jury.

Pharmaceutical and biotech businesses were enthusiastic about the UPC before the court opened, but so far there has only been ...

A trial team at Goodwin Procter won a $452 million verdict for client Insulet Corp. in a trade secrets case involving insulin pump technology against Korean rival EOFlow Co. A team at Paul ...

The company said it had restarted production of intravenous solutions on two lines in November, and added they were manufacturing 1-liter IV solution bags, the most commonly used size by hospitals and ...